EndTB-Q Output 5 testing new regimens to treat MDR-TB resistant to fluoroquinilones

Project Details

Description

Preparation and implementation of a clinical trial endTB-Q which relates to testing novel regimes to treat MDR-TB resistant to fluoroquinilones

Description

Preparation and implementation of a clinical trial endTB-Q which relates to testing novel regimes to treat MDR-TB resistant to fluoroquinilones
AcronymEndTB O5
StatusActive
Effective start/end date1/07/20 → 30/06/25

Funding

  • MSF France: €969,047.49